NCT00001181View on ClinicalTrials.gov

Testolactone for the Treatment of Girls With LHRH Resistant Precocious Puberty

PHASE2CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

October 31, 1982

Study Completion Date

May 31, 2003

Conditions
Polyostotic Fibrous DysplasiaPrecocious Puberty
Interventions
DRUG

Testolactone

Trial Locations (1)

20892

National Institute of Child Health and Human Development (NICHD), Bethesda

All Listed Sponsors
lead

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

NCT00001181 - Testolactone for the Treatment of Girls With LHRH Resistant Precocious Puberty | Biotech Hunter | Biotech Hunter